IL1B and neoplasm: We found that similarly to TEVs, the PD-L1 levels were higher in resistant cells and after IL-1β stimulation than the control cells, thus suggesting that TEVs and cancer cells, from which they are released, may synergistically contribute to tumor immune evasion.